4//SEC Filing
NovaBay Pharmaceuticals, Inc. 4
Accession 0001437749-13-013587
$NBYCIK 0001389545operating
Filed
Oct 28, 8:00 PM ET
Accepted
Oct 29, 8:42 PM ET
Size
15.6 KB
Accession
0001437749-13-013587
Insider Transaction Report
Form 4
Najafi Ramin
DirectorChief Executive OfficerOther
Transactions
- Tax Payment
Common Stock
2013-10-28$1.75/sh−4,557$7,975→ 100,195 total
Holdings
- 3,117,500(indirect: By Trust)
Common Stock
Issuer
NovaBay Pharmaceuticals, Inc.
CIK 0001389545
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001389545
Filing Metadata
- Form type
- 4
- Filed
- Oct 28, 8:00 PM ET
- Accepted
- Oct 29, 8:42 PM ET
- Size
- 15.6 KB